NPI 1073609442: Open Payments
NPI 1073609442. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$102 in 5 payments from 4 companies in 2025. Trend: 2023 $79 · 2024 $187 · 2025 $102
Food & beverage: $102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Novo Nordisk Inc | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
Products named: QULIPTA, TRELEGY ELLIPTA, Cologuard Collection Kit.
